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Purpose/Objective: Modern radiotherapy techniques such as IMRT and 
VMAT allow physicians to spare organs at risk of radiotherapy damage 
thereby improving quality of life (QoL) amongst survivors. In patients 
undergoing radical radiotherapy (RRT) for head and neck cancer, dose 
to SWOAR is increasingly being recognised as a determinant of QoL 
and long-term function such as dysphagia, regurgitation and tube 
dependency. Therefore, it has been proposed that limiting dose to 
SWOAR would be a desirable goal. However, there is no data on 
dosimetry of SWOAR during treatment or whether changes are 
potentially due to tumour response or inflammation thereby, 
supporting a strategy of enforcing strict dose constraints. 
This study aimed to document dosimetry of SWOAR using midway 
planning CT scan, whilst applying the original treatment plan as well 
as an adaptive plan generated de novo. 
Materials and Methods: 
 27 consecutive patients with head and neck cancer were CT-
simulated (SCAN 1) and a VMAT treatment plan (PLAN1) was 
generated to treat to a dose of 65Gy in 30 fractions (#). Patients 
completed treatment based on this plan.  
 Mid-treatment ie week 3, patients underwent a second CT-
simulation to acquire mid treatment planning image (SCAN2)  
 Retrospectively, the original treatment PLAN 1 was applied to 
the mid-treatment SCAN2 to create PLAN 2  
 In addition, a de novo plan or PLAN (ART) was generated using 
SCAN 2 but with the optimisation priorities and constraints 
unchanged from the first PLAN 1(this second plan was aimed to 
treat last 10 treatments to 21.67Gy in 10#)  
 Delineation of SWOARs was performed for Base of tongue (BOT), 
oesophageal inlet muscle (EIM), superior/middle/inferior 
pharyngeal constrictor muscle (SPCM/MPCM/IPCM), 
cricopharyngeal muscle (Crico), cervical oesophagus (CEso), 
supra-larynx and glottic larynxfor both treatment planning SCAN 
1 and SCAN 2 and mean and median dose to each SWOAR was 
obtained.  
A paired t-test was used to compare the dose to SWOAR between 
PLAN1 (clinical plan 30#) and PLAN1(20#) PLAN2(10#) to identify if 
there was a significant difference when a recalculation was performed 
and delivered for remaining 10#. This was repeated to evaluate a 
significant difference when PLAN ART was to be used for remaining 
10#. 
Results: Overall there was little difference in dosimetry to SWOAR 
whether treatment proceeded using the original plan recalculated 
(PLAN 2) or an adaptive plan generated de novo to optimise for PTV 
coverage (PLAN ART). The only significant difference was seen for 
Crico p=0.04, SPCM p=0.01 and EIM p=0.04 for PLAN 2 and for the 
Crico p=0.01 for PLAN ART used in conjunction with an adaptive plan. 
 
Conclusions: This study showed delineation and evaluation of dose to 
SWOAR at the initial planning stage was a reasonably good estimation 
of expected dose throughout treatment. Therefore applying treatment 
planning constraints at the outset, would be a reasonable strategy to 
reduce dose to SWOAR. Our data reveals there may be some concern 
over the variance in dosimetry to the cricopharyngeal muscle, 
superior inferior pharyngeal constrictor muscle and esophageal inlet 
muscle over the course of RRT treatment.  
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Purpose/Objective: Respiratory motion limits the efficacy of intensity 
modulated radiation therapy (IMRT) as larger treatment fields are 
required to prevent geographic misses. With respiratory-gated RT, the 
irradiated lung volume is reduced by the selection of beam-on-phase 
in the respiration cycle (i.e. the gating window). The aim of this study 
is to compare the lung dosimetric parameters at RT gated around 40%-
60% and 30%-70% windows of a respiratory cycle around end-
expiration. 
Materials and Methods: Thirteen NSCLC patients who underwent four-
dimensional computed tomography (4DCT) simulations were studied 
retrospectively. Patients were CT-scanned under normal respiration. 
Patients with tumor motion greater than 5 mm were selected for this 
study. For each patient, two CT datasets were reconstructed (40%-60% 
gating window and 30%-70% gating window). Planning target volumes, 
heart, esophagus, and spinal cord were contoured in the 40%-60% and 
the 30%-70% gating window CT data set. The lungs were contoured 
separately on both CT data sets. In the lung-contouring process, a 
Varian Eclipse treatment planning system automatic contouring tool 
was employed. Default CT threshold values were used. The lung 
contours were visually verified on each slice. Intensity-modulated 
radiotherapy plans were generated on the CT data sets with 40%-60% 
and 30%-70% gating window and doses were recomputed. The 
evaluation metric was based on dose indices and volume indices for 
targets and critical structures. Statistical tests were used to establish 
the significance of the differences between the different gating 
windows to find the optimal setting of the gating window of a 
respiratory cycle around end-expiration. 
Results: For all patients, homogeneity indices were similar for 30%-
70% and 40%-60% IMRT plans. PTV dose uniformity, as indicated by 
(D2%-D98%)/D50%, were all within 0.15 between 40%-60% and 30%-70% 
gating phases for 13 patients. 
The average mean lung dose was 3.1 Gy in the 40%-60% and 30%-70% 
gating phases. The V20 at 40%-60% and 30%-70% gating windows were 
4.5% and 4.3%, respectively; The V10 at 40%-60% and 30%-70% gating 
windows were 8.1% and 7.9%, respectively. The V5 at 40%-60% and 
30%-70% gating windows were 14.3% and 14.5%, respectively. The 
difference in dosimetric parameters of lung obtained with 40%-60% 
and 30%-70% gating windows were not statistically different.  
The average mean heart dose was 2.2 Gy in the 40%-60% and 30%-70% 
gating phases. The average mean esophagus dose was 2.4 Gy for 40%-
60% plans and 2.5 Gy for 30%-70% plans. The average D1% cord dose was 
10.4 Gy for 40%-60% plans and 10.8 Gy for 30%-70% plans. All the 
toxicity parameters of the organs at risk did not show any statistically 
significant correlation in both 40%-60% and 30%-70% plans. 
Conclusions: We found that lung dosimetric parameters and all the 
toxicity parameters of the organs at risk were comparable with gating 
was around 40%-60% or 30%-70% phases. Given that shorter treatment 
time in the 30%-70% gating windows, it may be more beneficial to 
deliver the therapy using this parameter. 
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Purpose/Objective: The use of a breath hold technique enables a 
significant decrease of the dose to the heart as well as the left 
anterior descending coronary artery (LAD). Radiation dose to the heart 
and LAD (i.e. the OARs) could result in long-term cardiac toxicity. A 
further decrease of the dose to both structures might be possible 
using proton therapy. We, therefore, examined whether the use of 
proton therapy (when compared to an IMRT technique) could 
eventually lead to a further decrease of the dose to the OARs. 
Materials and Methods: Twenty patients with left-sided breast cancer 
referred for radiotherapy after breast conserving surgery were 
included in our study. All patients underwent a free breathing (FB) 
and a breath hold (BH) 3D-CT-scan in supine treatment position. CTV 
and heart and LAD were delineated by one observer.  
PTV was composed according to institutional guidelines. All plans had 
to meet the criterion that 97% of PTV was covered by the 95% isodose 
(V95%). The prescribed dose was 42.56 Gy. 
